ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,880Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 680

$2M Total Retail Price of All Prescriptions

Rank: 7 out of 680

561 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 561 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

23% of this provider’s 561 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 25,913 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 969 860 1 2
LISINOPRIL 785 685 2 5
FAMOTIDINE 739 640 3 89
SIMVASTATIN 730 668 4 3
HYDROCODONE-ACETAMINOPHEN 686 524 S3 5 4
DONEPEZIL HCL 678 668 6 27
FUROSEMIDE 677 635 7 6
AMLODIPINE BESYLATE 633 578 8 1
ESCITALOPRAM OXALATE 572 518 9 45
METOPROLOL TARTRATE 510 440 10 12
NOVOLIN R 489 451 11 113
WARFARIN SODIUM 424 391 12 20
RISPERIDONE 420 335 13 80
KLOR-CON M20 399 336 14 61
NAMENDA 388 359 15 35
GABAPENTIN 386 342 16 15
OMEPRAZOLE 381 324 17 7
SERTRALINE HCL 368 278 18 28
METFORMIN HCL 368 349 18 8
QUETIAPINE FUMARATE 358 324 20 64
MIRTAZAPINE 357 313 21 78
METOPROLOL SUCCINATE 354 334 22 13
CITALOPRAM HBR 336 303 23 22
TRAZODONE HCL 335 241 24 48
CYMBALTA 306 268 25 46
LANTUS SOLOSTAR 291 251 26 84
SANTYL 290 276 27 170
OLANZAPINE 290 185 27 116
DIGOXIN 288 284 29 58
POLYETHYLENE GLYCOL 3350 272 233 30 62
HYDROCHLOROTHIAZIDE 261 232 31 9
TRAMADOL HCL 250 200 32 18
CLOPIDOGREL 243 202 33 26
ADVAIR DISKUS 239 192 34 53
AZITHROMYCIN 228 198 35 42
KLOR-CON M10 227 216 36 127
MEGESTROL ACETATE 209 193 R 37 88
ABILIFY 205 155 38 178
CEFUROXIME 202 185 39 179
PAROXETINE HCL 198 150 40 76
FLUTICASONE PROPIONATE 197 167 41 41
LACTULOSE 194 171 42 92
HALOPERIDOL 194 187 42 193
MELOXICAM 185 166 44 24
LEXAPRO 175 161 45 128
PLAVIX 175 145 45 39
CARVEDILOL 173 134 47 23
SPIRIVA 169 148 48 70
TAMSULOSIN HCL 162 158 49 34
NITROFURANTOIN MONO-MACRO 161 147 50 172
MUPIROCIN 156 132 51 130
DIOVAN 153 138 52 31
ATENOLOL 151 143 53 19
LEVETIRACETAM 151 114 53 120
NEXIUM 149 107 55 16
RANITIDINE HCL 149 140 55 56
ALENDRONATE SODIUM 148 120 57 32
PREDNISONE 146 129 58 50
SEROQUEL 144 128 59 123
METOCLOPRAMIDE HCL 142 123 60 118
IPRATROPIUM-ALBUTEROL 140 121 61 207
BUMETANIDE 135 121 62 102
PRAVASTATIN SODIUM 135 132 62 10
CLONIDINE HCL 135 126 62 36
LEVOFLOXACIN 134 121 65 97
OXYBUTYNIN CHLORIDE 130 91 66 129
NYSTOP 130 106 66 305
ISOSORBIDE MONONITRATE ER 129 126 68 59
DIVALPROEX SODIUM ER 125 72 69 148
DIVALPROEX SODIUM 124 75 70 110
VENLAFAXINE HCL ER 120 93 71 101
ROPINIROLE HCL 113 113 72 99
ATORVASTATIN CALCIUM 112 92 73 11
DETROL LA 110 63 74 169
GLIMEPIRIDE 104 96 75 29
PROAIR HFA 104 91 75 67
BACLOFEN 103 63 77 140
MECLIZINE HCL 101 91 78 103
SUCRALFATE 99 79 79 160
SULFAMETHOXAZOLE-TRIMETHOPRIM 97 89 80 94
CARBIDOPA-LEVODOPA 97 88 80 117
CIPROFLOXACIN HCL 96 90 82 57
POTASSIUM CHLORIDE 94 85 83 14
NOVOFINE AUTOCOVER 93 74 84 248
BENZTROPINE MESYLATE 90 66 R 85 137
PHENYTOIN SODIUM EXTENDED 88 85 86 115
VESICARE 83 83 87 176
NYSTATIN 81 62 88 191
GLYBURIDE 80 73 R 89 85
SEROQUEL XR 77 77 90 235
AMITRIPTYLINE HCL 76 75 R 91 47
TOPIRAMATE 73 38 92 233
ALLOPURINOL 71 59 93 33
HYDRALAZINE HCL 71 70 93 71
PATADAY 71 70 93 342
CEPHALEXIN 68 58 96 149
LEVEMIR FLEXPEN 68 51 96 186
PROMETHAZINE HCL 68 63 R 96 96
DOXEPIN HCL 68 68 96 200
FOSINOPRIL SODIUM 67 67 100 203
CYCLOBENZAPRINE HCL 67 44 R 100 81
ACTOS 65 57 102 114
DILTIAZEM 24HR CD 65 62 102 182
PANTOPRAZOLE SODIUM 65 58 102 30
BENAZEPRIL HCL 64 57 105 40
FLUCONAZOLE 64 53 105 139
ZOLPIDEM TARTRATE 64 50 105 17
FELODIPINE ER 63 55 108 146
CEFTRIAXONE 63 53 108 347
VENLAFAXINE HCL 63 53 108 239
OXYBUTYNIN CHLORIDE ER 62 62 111 143
BUSPIRONE HCL 62 57 111 144
SODIUM CHLORIDE 62 56 111 311
AGGRENOX 61 61 114 177
CRESTOR 61 26 114 25
LIPITOR 60 51 116 68
AMIODARONE HCL 60 33 116 158
CYPROHEPTADINE HCL 60 57 R 116 297
TRIAMCINOLONE ACETONIDE 57 51 119 199
MEGACE ES 57 50 R 119 280
COMBIVENT 57 47 119 168
NYSTATIN-TRIAMCINOLONE 57 50 119 310
LATANOPROST 56 56 123 209
GEMFIBROZIL 56 56 123 106
GLIPIZIDE 56 50 123 63
LIDOCAINE HCL 54 44 126 387
LYRICA 53 38 127 77
AMOX TR-POTASSIUM CLAVULANATE 52 41 128 124
LIDODERM 52 46 128 221
TRICOR 52 44 128 98
CELEBREX 51 51 131 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.